Paradigm Biocapital Advisors LP - 30 Sep 2025 SCHEDULE 13G/A Report for LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share (LENZ)

Filing Manager: Paradigm Biocapital Advisors LP
Reporting Manager: Paradigm BioCapital Advisors LP
Security: LENZ Therapeutics, Inc. Common Stock, $0.00001 par value per share
Symbol: LENZ
Shares outstanding: 28,248,974 shares
Disclosed Ownership: 1,073,461 shares
Ownership: 3.8%
Form type: SCHEDULE 13G/A
Filing time: 14 Nov 2025, 16:32:28 UTC
Date of event: 30 Sep 2025
Previous filing: 27 Mar 2025
SEC: View on sec.gov

Reporting Managers (4)

Name	Ownership	Shares Owned	sole voting power	Signature	Title
Paradigm BioCapital Advisors LP	3.8%	1,073,461	1,073,461	/s/ David K. Kim	David K. Kim / Authorized Signatory
Paradigm BioCapital Advisors GP LLC	3.8%	1,073,461	1,073,461	/s/ David K. Kim	David K. Kim / Authorized Signatory
Senai Asefaw, M.D.	3.8%	1,073,461	1,073,461	/s/ Senai Asefaw, M.D.	N/A
Paradigm BioCapital International Fund Ltd.	3.3%	946,447	946,447	/s/ David K. Kim	David K. Kim / Authorized Signatory